-
Product Insights
Likelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
Product Insights
Likelihood of Approval Analysis for Rheumatoid Arthritis
Overview How likely is it that the drugs in Rheumatoid Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized...
-
Product Insights
Likelihood of Approval Analysis for Esophageal Squamous Cell Carcinoma (ESCC)
Overview How likely is it that the drugs in Esophageal Squamous Cell Carcinoma (ESCC) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esophageal Squamous Cell Carcinoma (ESCC) Overview Esophageal squamous cell...
-
Product Insights
Likelihood of Approval Analysis for Gastroesophageal (GE) Junction Carcinomas
Overview How likely is it that the drugs in Gastroesophageal (GE) Junction Carcinomas will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gastroesophageal (GE) Junction Carcinomas Overview Gastroesophageal (GE) junction carcinomas are...
-
Product Insights
Likelihood of Approval Analysis for Human Papillomavirus Infections
Overview How likely is it that the drugs in Human Papillomavirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Human Papillomavirus Infections Overview Human Papillomavirus (HPV) infections are common sexually...
-
Product Insights
Likelihood of Approval Analysis for Genital Warts (Condylomata Acuminata)
Overview How likely is it that the drugs in Genital Warts (Condylomata Acuminata) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genital Warts (Condylomata Acuminata) Overview Genital warts (condyloma acuminatum) are...
-
Product Insights
Likelihood of Approval Analysis for Hepatitis B
Overview How likely is it that the drugs in Hepatitis B will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatitis B Overview Hepatitis B, a viral infection affecting the liver, poses...
-
Product Insights
Likelihood of Approval Analysis for Mucopolysaccharidosis
Overview How likely is it that the drugs in Mucopolysaccharidosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mucopolysaccharidosis Overview Mucopolysaccharidosis (MPS) refers to a group of inherited metabolic disorders causing...
-
Product Insights
Likelihood of Approval Analysis for Bone Metastasis
Overview How likely is it that the drugs in Bone Metastasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Metastasis Overview Bone metastasis occurs when cancer cells spread from their...
-
Product Insights
Likelihood of Approval Analysis for Autism Spectrum Disorder (ASD)
Overview How likely is it that the drugs in Autism Spectrum Disorder (ASD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Autism Spectrum Disorder (ASD) Overview Autism Spectrum Disorder (ASD) is...